9 Pharmacodynamics Flashcards

1
Q

What is an agonist and what do they require for it to function

A

Drugs activating the receptor

-Affinity for the receptor
-Intrinsic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an antagonist and what do they require for it to function

A

Drugs binding to receptor and blocking the binding of their ligands (exo/endogenous)

-Affinity for the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is binding measured? Give an example

A

Calculate the amount of (radio) ligand bound specifically to the receptor

e.g.) binding of fluorescent compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Difference between pharmacological efficacy and clinical efficacy

A

Pharmacological efficacy: The ability to activate a receptor and cause conformational change

Clinical efficacy: An indication of how well treatment succeeds in achieve in its aim
E.g.) does this drug lower BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Kd and what does a lower value of this suggest

A

Index of affinity of the drug for the receptor
(half of Bmax)
Lower value = Higher affinity
-Lower conc. required to occupy 50% of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

E.g.) Drug A: Kd= 10^-9, Drug B: Kd=10^-3 (Both lnM)
Which has a higher affinity ?

A

Drug AA has a higher affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is response against agonist be seen

A

-change in signalling pathway
-change in cell/tissue behaviour
e.g.) contraction

Response required drug efficacy (agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the importance of affinity to ligands in pharmacological context ?
Give an example

A

High affinity allows binding at low conc. of hormones, neurotransmitters

e.g.) Opioid overdose used to be treated by naloxone since it is a high affinity antagonist of m-opioid receptors and outcompetes opioid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the relationship between the proportion of bound receptors and drug conc.

A

The proportion of bound receptors is logarithmically changing as the drug conc. increases
NOT linear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is drug POTENCY and what does it depend on

A

How much drug you require to cause a response

It depends on
-affinity
-intrinsic efficacy
-cell/tissue -specific components (opening the door)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Bmax

A

Max. binding capacity of a receptor
(half of Bmax is EC50)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Emax

A

Max. threshold rate that a drug can act on a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is EC50

A

Drug Potency
-effective conc. giving 50% of the max. response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Difference between dose and concentration

A

Dose: Conc. at the site of action, generally unknown
E.g.) dose to a patient in in mg/kg

Conc.: known conc. of drug at site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between selectivity and specificity in terms of ligand-receptor complexes

A

Specificity: The preference of a ligand for one specific receptor
Selectivity: The preference one a ligand for a receptor over another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is selectivity/specificity achieved in drugs against asthma

A

Salbutamol:β2- selective efficacy
Salmeterol: no selective efficacy, selectivity based on affinity (β1-↑rate of heart contraction)

β2-adrenoreceptors opens up airways.
Salbutamol is a more suitable drug since it has selective efficacy to act on β2 than β1

17
Q

Relationship between agonist affinity and agonist potency

A

Expectation: 100% binding, 100% response
Commonly seen: 50% binding, 100% response

The difference is caused by spare receptors

18
Q

What does it mean when EC50 is less than Kd

A

There are spare receptors
-often seen when receptors are catalytically active e.g.) GPCR

19
Q

Why do spare receptors exist

A

-Amplification in the signal transduction pathway
-Response is limited by a post-receptor event

20
Q

What is the importance of spare receptors

A

Increase sensitivity/potency and allow responses at low. conc of agonist

21
Q

What does the receptor no. depend on

A

-cell type
-level of activity
(low: increase in cell type, high: decrease in cell type)

22
Q

What is intrinsic activity and how is it measured

23
Q

Difference between full agonist and partial agonist

A

Full agonist: (often endogenous)
Partial agonist: lower intrinsic activity due to lower efficacy

24
Q

What does partial agonist depend on

A

-ligand type
-receptor no.

25
How can a partial agonist become a full agonist
Increasing receptor no. (the increased no. of receptors can compensate the low intrinsic efficacy to produce a full response)
26
What is the relevance of partial agonists as drugs Give an example
Allows a more controlled response e.g.) Opioids: pain relief, recreational use BUT respiratory depression can lead to death
27
How is opioid addiction treated by partial agonists
Heroin: produces full response Buprenorphine: higher affinity (occupies receptors & limits response) Buprenorphine will inhibit the effect of heroin (provide antagonism)
28
How is antagonism achieved
1. Functional Antagonism (e.g. Effect of drugs on asthma) 2. Antagonist (antagonism of an action of an agonist at its receptor using a ligand)
29
What is a Receptor antagonist and the different types of this
It blocks the effects of agonists 1. Reversible competitive antagonism (common) 2. Irreversible competitive antagonism 3. Non-competitive antagonism
30
Describe Reversible competitive antagonism
Antagonists compete with agonists for binding -surmountable -greater [antagonist] = greater inhibition
31
How do Reversible competitive antagonists affect the agonist concentration-response curve?
Causes a parallel shift to the right of the agonist concentration-response curve
32
Clinical example of Reversible Competitive Antagonism
Naloxone: higher affinity than heroin at μ-opioid receptors and competed effectively
33
Describe irreversible competitive antagonism
The antagonist dissociates slowly/not at all -non-surmountable
34
Give a clinical example of irreversible competitive antagonism
Pheochromocytoma (tumour of adrenal chromaffin cells) Non-selective irreversible α1-adrenoreceptors blocker: once bound, can't be outcompeted by high levels of adrenaline
35
Describe non-competitive antagonism
Antagonist binds to allosteric site -molecules that enhance/reduce effects of agonists -no competition -thus negative allosteric modulation
36
Clinical example of non-competitive antagonism
Maraviroc: Negative allosteric modulator of chemokine receptor 5 (used by HIV to enter cells) -Used in AIDS